Skip to main content
Irwin Naturals Inc. logo

Irwin Naturals Inc. — Investor Relations & Filings

Ticker · IWIN ISIN · CA46414Q1054 LEI · 9845003CF0B7JE8FAX54 CSE Manufacturing
Filings indexed 255 across all filing types
Latest filing 2022-05-30 Regulatory Filings
Country CA Canada
Listing CSE IWIN

About Irwin Naturals Inc.

https://irwinnaturals.com/

Irwin Naturals Inc. is a nutraceutical company focused on developing and distributing premium health supplements and vitamins. The company specializes in soft-gel based herbal formulas, prioritizing superior potency, bioavailability, and absorption. Its product portfolio includes targeted formulas for general wellness, sleep, cognitive function, detoxification, and weight management, alongside a range of CBD and THC products. A core unique selling proposition is the utilization of an all-liquid soft-gel delivery system combined with the signature BioPerine Complex, which is designed to enhance nutrient uptake. Irwin Naturals distributes its extensive line of supplements through mass-market and health food chain retailers across North America.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-05-30 English
Interim MD&A - English.pdf
Regulatory Filings
2022-05-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-05-30 English
News release - English.pdf
Regulatory Filings
2022-05-21 English
News release - English.pdf
Regulatory Filings
2022-05-20 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the acquisition of a healthcare clinic by Irwin Naturals. It discusses the transaction terms, company background, regulatory overview, and forward-looking statements. There are no financial statements, detailed financial performance data, or comprehensive management analysis typical of annual or interim reports. It is not a transcript, audit report, or governance document. The content focuses on a merger/acquisition activity with details about the deal and strategic intent. Therefore, the document fits best under the category of M&A Activity (TAR). The document length (7065 characters) and content confirm it is a full announcement rather than a brief notice or regulatory filing.
2022-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.